Table 2.
SNP | Gene | Chr | EA | MDACC
|
Harvard
|
Meta
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MAF | HR (95%CI) | P* | FPRP | MAF | HR (95%CI) | P** | HR(95%CI) | P | I2 | Phet | ||||
rs6426914 | RXRG | 1 | G | 0.06 | 2.04 (1.18 – 3.53) | 1.10×10−2 | 0.171 | 0.06 | 0.82 (0.32–2.07) | 0.669 | 1.40 (0.58 – 3.30) | 0.453 | 63.60 | 0.099 |
rs283695 | RXRG | 1 | A | 0.45 | 1.68 (1.24 – 2.29) | 9.00×10−4 | 0.011 | 0.44 | 0.87 (0.57–1.31) | 0.492 | 1.23 (0.65 – 2.34) | 0.534 | 84.18 | 0.013 |
rs285480 | RXRG | 1 | G | 0.22 | 1.47 (1.06 – 2.04) | 2.05×10−2 | 0.165 | 0.22 | 1.14 (0.72–1.80) | 0.581 | 1.35 (1.03 – 1.76) | 0.027 | 0.00 | 0.376 |
rs3767332 | RXRG | 1 | A | 0.24 | 0.59 (0.39 – 0.89) | 1.10×10−2 | 0.120 | 0.24 | 0.91 (0.57–1.46) | 0.687 | 0.72 (0.47 – 1.10) | 0.127 | 46.23 | 0.175 |
rs157861 | RXRG | 1 | G | 0.21 | 1.51 (1.09 – 2.08) | 1.23×10−2 | 0.099 | 0.19 | 0.97 (0.59–1.60) | 0.914 | 1.26 (0.83 – 1.93) | 0.285 | 53.64 | 0.144 |
rs115079560 | RXRG | 1 | C | 0.16 | 1.65 (1.18 – 2.30) | 3.08×10−3 | 0.031 | 0.14 | 0.87 (0.48–1.58) | 0.654 | 1.26 (0.68 – 2.34) | 0.467 | 70.55 | 0.066 |
rs3753896 | RXRG | 1 | G | 0.38 | 1.58 (1.15 – 2.15) | 4.35×10−3 | 0.034 | 0.35 | 0.88 (0.57–1.34) | 0.541 | 1.20 (0.68 – 2.13) | 0.531 | 78.92 | 0.030 |
rs3820367 | RXRG | 1 | G | 0.21 | 1.51 (1.11 – 2.04) | 7.95×10−3 | 0.063 | 0.21 | 0.87 (0.52–1.46) | 0.597 | 1.19 (0.70 – 2.04) | 0.514 | 69.19 | 0.071 |
rs2194899 | RXRG | 1 | A | 0.37 | 1.51 (1.13 – 2.01) | 5.18×10−3 | 0.042 | 0.34 | 0.72 (0.46–1.14) | 0.159 | 1.07 (0.52 – 2.20) | 0.863 | 86.20 | 0.007 |
rs3753898 | RXRG | 1 | G | 0.21 | 1.44 (1.06 – 1.95) | 1.84×10−2 | 0.144 | 0.20 | 0.84 (0.49–1.43) | 0.515 | 1.15 (0.69 – 1.94) | 0.593 | 66.11 | 0.086 |
rs1529382 | CYP27A1 | 2 | T | 0.49 | 1.70 (1.26 – 2.31) | 6.00×10−4 | 0.007 | 0.50 | 1.25 (0.83–1.89) | 0.282 | 1.50 (1.12 – 2.02) | 0.007 | 28.86 | 0.238 |
rs12512631 | VDBP | 4 | C | 0.36 | 0.70 (0.51 – 0.95) | 2.41×10−2 | 0.168 | 0.35 | 0.58 (0.36–0.93) | 0.025 | 0.66 (0.51 – 0.86) | 1.88×10−3 | 0.00 | 0.516 |
rs7850212 | RXRA | 9 | A | 0.11 | 0.41 (0.21 – 0.78) | 7.15×10−3 | 0.179 | 0.09 | 0.31 (0.10–0.97) | 0.043 | 0.38 (0.22 – 0.68) | 9.54×10−4 | 0.00 | 0.676 |
rs67965144 | RXRA | 9 | A | 0.12 | 1.52 (1.07 – 2.16) | 2.04×10−2 | 0.158 | 0.13 | 0.79 (0.43–1.48) | 0.469 | 1.15 (0.61 – 2.17) | 0.656 | 68.86 | 0.071 |
rs62576319 | RXRA | 9 | T | 0.11 | 1.71 (1.17 – 2.49) | 5.12×10−3 | 0.055 | 0.12 | 1.00 (0.55–1.82) | 0.992 | 1.38 (0.82 – 2.31) | 0.222 | 54.59 | 0.137 |
rs12895681 | SNW1 | 14 | T | 0.32 | 1.42 (1.06 – 1.90) | 1.81×10−2 | 0.142 | 0.35 | 0.92 (0.59–1.43) | 0.719 | 1.18 (0.78 – 1.80) | 0.439 | 61.72 | 0.109 |
rs12890375 | SNW1 | 14 | G | 0.26 | 0.66 (0.45 – 0.95) | 2.45×10−2 | 0.197 | 0.27 | 1.10 (0.71–1.72) | 0.664 | 0.84 (0.51 – 1.39) | 0.490 | 66.68 | 0.084 |
rs77513685 | NCOA3 | 20 | T | 0.21 | 1.50 (1.07 – 2.12) | 2.01×10−2 | 0.170 | 0.21 | 1.52 (0.98–2.35) | 0.061 | 1.51 (1.15 – 1.97) | 0.003 | 0.00 | 0.963 |
EA = effect allele; MAF=minor allele frequency; HR = hazards ratio; LHR = lower hazards ratio; UHR = upper hazards ratio; FPRP = false positive report probability; Phet = P heterogeniety;
A2 is the effect allele;
Adjusted by age, sex, tumor stage, Breslow thickness, Clark level and ulceration of tumor;
Adjusted by age, sex.